Sera Prognostics lands $36 mln Series D

Salt Lake City-based Sera Prognostics Inc, a health diagnostics company, has secured $36 million in Series D funding. Blue Ox Healthcare Partners led the round with participation from other investors that included Domain Associates, InterWest Partners, Laboratory Corporation of America Holdings, Catalyst Health Ventures and Chione Ltd.

DealsManagersNorth AmericaUSHealthcareBriefs